HERZLIYA, Israel, July 31, 2018 /PRNewswire-PRWeb/ --áIn today's highly competitive market, ORCA's immediate cephalometric
Known for their machine learning and deep learning technologies, ORCA Dental AI develops unique dental algorithms that can identify the dental imagery visuals and produce exceptional cephalometric tracing and analysis in real time.
About ORCA Dental AI
For over 15 years, ORCA Dental AI has been investing in research and development to create highly sophisticated, market-leading cephalometric analyses capabilities, which are already used and trusted by thousands of practitioners worldwide.
CephX, ORCA's first algorithm, allows the most advanced cephalometric tracing and analysis solution that utilizes Artificial Intelligence technology to streamline the orthodontic pre-treatment process. This solution optimizes orthodontist's and dentist's work by providing automated, immediate and accurate analyses in just few seconds.
ORCA envisions a world where diagnostics, visual treatment suggestions and pathology findings are immediately and seamlessly rendered. This includes all types of dental imagery, namely Cephs, CBCT, intraoral scans and periapical X-rays. For more information about ORCA's solutions, visit http://www.orca-dental.ai.
About Coast Dental
Since 1992, patients have trusted the Coast Dental family of dentists to provide quality care in a friendly, caring environment. Their trust has made Coast Dental one of the largest dental providers in the U.S. Coast Dental, along with its professional affiliations, has more than 180 locations in California, Florida, Georgia, Nevada and Texas. Its convenient locations make it easy to maintain a regular schedule of dental visits and keep the smile beautiful and healthy. For more information about Coast Dental's clinics and services, visit http://www.coastdental.com.
SOURCE PRWeb House E-Commerce
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All